(Institución)
 
 

Docu-menta >

Statistics

Total Visits

Views
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment 318

Total Visits per Month

July 2025 August 2025 September 2025 October 2025 November 2025 December 2025 January 2026
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment 17 20 15 20 22 14 2

File Downloads

Views
23. Navarro- MOL THERAPY MCD 2021.pdf 173

Top Country Views

Views
España 318

Top City Views

Views
Madrid 318

 

Información y consultas: documenta@ciemat.es | Documento legal